Contrast Media and Reactions Practice Questions

Q: Iodine particle ratio for Ionic dimer is

6:2. ***6:2*** - An **ionic dimer** contrast agent contains **six iodine atoms** (three on each monomer unit) and **two osmotically active particles** in solution (one dimer anion and one counter-cation such as sodium or meglumine). - This results in a ratio of **6 iodine atoms** to **2 osmotically active particles**, giving an iodine-to-particle ratio of **6:2** (or 3:1 when simplified). *6:1* - This ratio would imply that for six iodine atoms, there is only **one osmotically active particle**, which is not correct for an ionic dimer. - Ionic dimers dissociate into **two particles** (the dimer anion and its counter-cation), so a 6:1 ratio is chemically incorrect for this type of contrast agent. *3:2* - This ratio accurately describes an **ionic monomer**, not an ionic dimer. - An ionic monomer has **three iodine atoms** and dissociates into **two particles**, giving a 3:2 ratio. - An ionic dimer has **six iodine atoms** (double that of a monomer), making this ratio incorrect for ionic dimers. *2:6* - This ratio is the inverse of the correct answer and implies **fewer iodine atoms** than osmotically active particles, which is physically impossible. - An ionic dimer has **more iodine atoms** (6) than osmotically active particles (2), making this ratio completely incorrect.

Q: Excretory urography is contraindicated in:

Multiple myeloma. ***Multiple myeloma*** - Patients with **multiple myeloma** are at high risk of developing **contrast-induced nephropathy** due to the precipitation of Bence Jones proteins in renal tubules when exposed to iodinated contrast agents. - This can lead to **acute kidney injury** or worsening of pre-existing renal impairment, making excretory urography generally contraindicated. *Single kidney* - While careful consideration is needed, having a **single kidney** does not inherently contraindicate excretory urography if renal function is good. - The primary concern is protecting the remaining kidney from **contrast-induced nephropathy** in patients with pre-existing renal dysfunction, not the number of kidneys. *Trauma* - In cases of **renal trauma**, excretory urography (or more commonly, CT urography) can be used to assess the extent of injury and integrity of the urinary tract. - It is often indicated to evaluate **hematuria** or suspected kidney damage, not contraindicated. *Renal artery hypertension* - Excretory urography was historically used to evaluate for **renal artery stenosis**, a cause of **renal artery hypertension**, by looking for delayed contrast excretion or kidney size differences. - While it has largely been replaced by more modern imaging like CT angiography or MRA, it is not considered a contraindication and can provide some diagnostic information.

Q: All of the following dyes are water soluble except:

Myodil. ***Myodil*** - **Myodil** (Iophendylate) is an **oil-based** contrast medium previously used for myelography. - Due to its **oil-based nature**, it is not water-soluble and had to be removed after the procedure to prevent complications. *Iohexol* - **Iohexol** is a **non-ionic, water-soluble** contrast agent commonly used in various radiological procedures, including myelography. - Its water solubility allows for easy absorption and excretion from the body. *Conray 420* - **Conray 420** (Iothalamate meglumine) is an **ionic, water-soluble** contrast agent often used for angiography and urography. - It readily mixes with bodily fluids due to its water-soluble properties. *Metrizamide* - **Metrizamide** was an early **non-ionic, water-soluble** contrast agent specifically developed for myelography. - Although water-soluble, it had a higher incidence of neurotoxicity compared to newer agents like iohexol.

Q: Dye used in IV cholangiography is:

Billigraffin. ***Billigraffin*** - **Billigraffin** (also known as sodium **iodipamide**) was historically the **primary contrast agent** used in intravenous (IV) cholangiography. - It is an **iodinated contrast medium** specifically designed for excretion into the **biliary system**, allowing visualization of the bile ducts. *Conray* - **Conray** (iothalamate meglumine) is a general-purpose **ionic iodinated contrast medium** primarily used for **angiography, CT scans**, and **excretory urography**. - It is not specifically formulated for optimal **biliary excretion** and would not provide adequate visualization for IV cholangiography. *Myodil* - **Myodil** (iophendylate) is an **oil-based iodinated contrast medium** that was historically used for **myelography** to visualize the spinal canal. - Due to its **oil-based nature** and different excretion pathway, it is entirely unsuitable for **IV cholangiography**. *Dianosil* - **Dianosil** was a trade name for certain **bronchography contrast agents** containing iodized oil, used to visualize the tracheobronchial tree. - This type of contrast medium is designed for **pulmonary application** and would not be used for imaging the biliary system.

Q: Dye used for "Myelography" is:

Iohexol (Omnipaque). ***Iohexol (Omnipaque)*** - Iohexol is a **non-ionic, low-osmolar monomeric contrast agent** and is the **most commonly used agent for myelography** worldwide. - It is **FDA-approved for intrathecal use** and has extensive safety data with **low neurotoxicity**. - Its widespread availability and proven safety profile make it the **standard choice** for myelography in clinical practice. *Iopamidol (Isovue)* - Iopamidol is also a **non-ionic, low-osmolar monomeric agent** that is FDA-approved for myelography. - While it is a suitable alternative to iohexol, **iohexol remains more commonly used** in most centers. - Both agents have similar safety profiles for intrathecal administration. *Iodixanol (Visipaque)* - Iodixanol is an **iso-osmolar dimeric contrast agent** primarily used for **cardiac and vascular imaging**. - While theoretically advantageous due to iso-osmolarity, it has **limited approval and use for myelography** compared to iohexol. - It is **not the standard or most commonly used agent** for this procedure. *Barium sulfate* - This is an **insoluble oral or rectal contrast agent** used exclusively for gastrointestinal imaging. - It is **absolutely contraindicated for intrathecal use** as it causes severe neurotoxicity and potentially fatal reactions. - Only **water-soluble iodinated contrast agents** should be used for myelography.

Q: Gadolinium is a contrast agent used for:

MRI - Imaging. ***MRI - Imaging*** - **Gadolinium** is a paramagnetic substance commonly used as a contrast agent in **Magnetic Resonance Imaging (MRI)**. - It works by altering the **T1 relaxation times** of protons in tissues, enhancing the signal and improving the visibility of certain structures or pathologies like **tumors** or **inflammation**. *CT - angiography* - **CT angiography** typically uses **iodine-based contrast agents**, not gadolinium, to visualize blood vessels. - Iodine contrast agents work by absorbing X-rays, making blood vessels appear bright on CT images. *Bronchography* - **Bronchography** is an older imaging technique that involved introducing an **iodinated contrast medium** directly into the bronchial tree. - It has largely been replaced by **high-resolution CT scans** for evaluating airways. *Contrast Sonography* - **Contrast-enhanced ultrasound (CEUS)**, or contrast sonography, primarily uses **microbubble contrast agents** made of inert gas. - These microbubbles enhance the reflectivity of blood, improving visualization of blood flow and organ perfusion.

Q: Non-Iodine containing contrast is

Gd DTPA. ***Gd DTPA*** - **Gadolinium-DTPA** (diethylenetriamine pentaacetic acid) is a **gadolinium-based contrast agent** used in MRI, which does not contain iodine. - It enhances images by shortening the **T1 relaxation time** of protons in tissues. *Diatrizoate* - **Diatrizoate** is an **iodinated contrast medium** commonly used in radiography and CT scans. - It contains iodine, which opacifies structures by **attenuating X-rays**. *Visipaque* - **Visipaque** (Iodixanol) is an **iodinated, non-ionic, dimeric contrast medium** with iso-osmolar properties. - It explicitly contains iodine as the contrast-enhancing element. *Iohexol* - **Iohexol** is another widely used **iodinated, non-ionic contrast agent** for various radiological procedures. - Its mechanism of action relies on the presence of iodine atoms to block X-rays.

Q: Which of the following contrast agents is used in USG?

SonoVue. ***SonoVue*** - **SonoVue** (also known as Lumason in the US) is the most commonly used **microbubble contrast agent** specifically designed for **ultrasonography (USG)**. - Contains **sulphur hexafluoride gas microbubbles** stabilized by a phospholipid shell. - These microbubbles enhance the echogenicity of blood, improving the visualization of blood flow and tissue perfusion in various organs, particularly in **liver imaging** and **cardiac echocardiography**. - Other USG contrast agents include Definity and Optison. *Urograffin* - **Urograffin** (diatrizoate) is an iodine-based contrast agent primarily used in **X-ray imaging**, particularly for **urography (imaging of the urinary tract)** and **angiography**. - It is not suitable for USG as it does not produce the necessary acoustic impedance difference for ultrasound enhancement. *Omnipaque* - **Omnipaque** (iohexol) is a non-ionic, low-osmolar **iodinated contrast agent** used for various **X-ray and CT procedures**. - Like other iodinated agents, its properties are optimized for X-ray attenuation, not for ultrasound enhancement. *Conray* - **Conray** (iothalamate) is an older generation, high-osmolar, **iodinated contrast agent** used for various **X-ray procedures** like angiography and CT scans. - Similar to Urograffin, it works by X-ray attenuation and is not effective for ultrasound contrast enhancement.

Q: Excretory urography should be cautiously performed in

Multiple myeloma. ***Multiple myeloma*** - Excretory urography (intravenous pyelography or IVP) involves the administration of **iodinated contrast media**, which can precipitate **Bence Jones proteins** in the renal tubules, leading to or worsening **acute kidney injury** in patients with multiple myeloma. - Patients with multiple myeloma often have **pre-existing renal dysfunction** (myeloma kidney) due to light chain deposition, making them highly susceptible to contrast-induced nephropathy. *Bone metastases* - While bone metastases can be painful and may require imaging, they do not directly contraindicate excretory urography; the primary concern with IVP is renal function. - The presence of bone lesions itself does not increase the risk of **contrast-induced nephropathy** in the same way that proteinuria from multiple myeloma does. *Neuroblastoma* - Neuroblastoma is a **childhood cancer** affecting the adrenal glands or sympathetic nervous system, and it is not typically associated with a specific risk for contrast-induced nephropathy from excretory urography. - The primary diagnostic imaging for neuroblastoma often involves ultrasound, CT, or MRI, and while contrast may be used, the specific renal risk seen in multiple myeloma is not present. *Leukemia* - While some forms of leukemia can affect the kidneys, particularly through infiltration, it does not typically pose the same specific risk for **contrast-induced nephropathy** as multiple myeloma. - The renal manifestations in leukemia are generally different from the **light chain proteinuria** seen in multiple myeloma, which directly interacts with iodinated contrast.

Q: What is the diagnosis for this patient with end-stage renal disease who developed skin changes after an imaging procedure?

Nephrogenic systemic fibrosis. **Nephrogenic systemic fibrosis** * This condition is strongly associated with exposure to **gadolinium-based contrast agents** in patients with severe **renal insufficiency** or **end-stage renal disease (ESRD)**. * It presents with **skin thickening** and hardening, often involving the extremities and trunk, which can progress to joint contractures and immobility. *Porphyria cutanea tarda* * This is a **disorder of heme synthesis** characterized by **fragile skin**, **blistering**, and **hypertrichosis** in sun-exposed areas [1]. * While it can be associated with liver disease and sometimes seen in patients with ESRD, it is not directly linked to contrast media exposure [1]. *Calciphylaxis* * This severe and rare syndrome involves **vascular calcification** and **skin necrosis**, predominantly seen in patients with ESRD. * It typically presents as painful, violaceous skin lesions that progress to ulcers, and while connected to ESRD, it is not triggered by imaging procedures. *Actinic elastosis* * This condition refers to **degeneration of elastic tissue in the skin** due to chronic and excessive **sun exposure**. * It is characterized by thickened, wrinkled, and yellowed skin and is not related to kidney disease or contrast agent exposure.

Question 1

Iodine particle ratio for Ionic dimer is

Accepted Answer

6:2

Answer

6:1

Answer

3:2

Answer

2:6

Question 2

Excretory urography is contraindicated in:

Accepted Answer

Multiple myeloma

Answer

Single kidney

Answer

Trauma

Answer

Renal artery hypertension

Question 3

All of the following dyes are water soluble except:

Accepted Answer

Myodil

Answer

Iohexol

Answer

Conray 420

Answer

Metrizamide

Question 4

Dye used in IV cholangiography is:

Accepted Answer

Billigraffin

Answer

Conray

Answer

Myodil

Answer

Dianosil

Question 5

Dye used for "Myelography" is:

Accepted Answer

Iohexol (Omnipaque)

Answer

Barium sulfate

Answer

Iodixanol (Visipaque)

Answer

Iopamidol (Isovue)

Question 6

Gadolinium is a contrast agent used for:

Accepted Answer

MRI - Imaging

Answer

CT - angiography

Answer

Bronchography

Answer

Contrast Sonography

Question 7

Non-Iodine containing contrast is

Accepted Answer

Gd DTPA

Answer

Diatrizoate

Answer

Visipaque

Answer

Iohexol

Question 8

Which of the following contrast agents is used in USG?

Accepted Answer

SonoVue

Answer

Urograffin

Answer

Omnipaque

Answer

Conray

Question 9

Excretory urography should be cautiously performed in

Accepted Answer

Multiple myeloma

Answer

Bone metastases

Answer

Neuroblastoma

Answer

Leukemia

Question 10

What is the diagnosis for this patient with end-stage renal disease who developed skin changes after an imaging procedure?

Accepted Answer

Nephrogenic systemic fibrosis

Answer

Porphyria cutanea tarda

Answer

Calciphylaxis

Answer

Actinic elastosis

Contrast Media and Reactions — MCQs

Contrast Media and Reactions — MCQs

On this page

Practice by Chapter

Want unlimited practice?